Inuprin Forte 100mg / ml inosine pranobex, antiviral syrup 100ml
The active substance contained in the drug - inosine pranobex, has antiviral properties and stimulates the activity of the immune system. Inuprin Forte 100mg / ml syrup is indicated for use in adults and children over 1 year of age.
Composition of Inuprin Forte 100mg / ml inosine pranobex, antiviral syrup:
Active substance: inosine pranobex (Inosinum pranobexum). One ml contains 100 mg of inosine pranobex and the excipients: sucrose, glycerol (E422), propylene glycol (E1520), methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), raspberry flavor AR0616 / G: aromatics, aromatic glycol ( E 1520), sodium hydroxide, citric acid, purified water.
Action of Inuprin Forte 100mg / ml inosine pranobex, antiviral syrup:
The active substance of the drug is inosine pranobex. It has antiviral properties and also stimulates the activity of the immune system. Inuprin Forte 100mg / ml syrup is indicated for use in adults and children over 1 year of age as an adjuvant in the case of reduced immunity, recurrent infections of the upper respiratory tract, as well as in the treatment of herpes on the lips and face caused by the herpes simplex virus (Herpes simplex). The drug is intended only for people who have previously been diagnosed with an infection with the herpes simplex virus.
inosine pranobex, antiviral syrup Application:
Inuprin Forte 100mg / ml syrup indicated for use as an adjuvant in the case of reduced immunity, in the case of recurrent respiratory infections and in the treatment of herpes on the lips and face caused by the herpes simplex virus - in people who have been diagnosed with an infection in the past herpes simplex virus. For use in adults and children over 1 year of age.
Additional inosine pranobex, antiviral syrup information:
Store the product out of reach of children, at room temperature. It is recommended to protect against moisture and light. Check with your doctor or pharmacist before using the drug if: in the past, you have gout attacks or increased levels of uric acid in the serum or in the urine; a history of nephrolithiasis or gallstones; have kidney problems (if treatment lasts 3 months or more, your doctor will carry out regular blood tests and will monitor your kidney and liver function. During long-term treatment, kidney stones may form). Discontinue treatment and contact your doctor if you develop symptoms of an allergic reaction: rash, itching, difficulty breathing, swelling of the face, lips, throat or tongue. Use in children: do not use under 1 year of age. Use during pregnancy and breastfeeding: if your doctor tells you otherwise, do not use during pregnancy and breastfeeding. Your doctor will assess whether the benefits of the drug outweigh the possible risks. Some medications may interact with inosine pranobex, including drugs for the treatment of gout; uricosuric drugs including diuretics, eg furosemide, torasemide, ethacrynic acid, hydrochlorothiazide, chlorthalidone, indapamide; medicines that suppress the immune system (immunosuppressants); medicines for HIV infection (azidothymidine). The drug may affect your ability to drive or operate machinery. The drug contains sucrose (0.65 mg in 1 ml) - the possibility of using it in people with diagnosed intolerance to certain sugars should be discussed with a doctor. Sugar content should be taken into account in people with diabetes. The drug contains glycerol (E422) - this may cause headache, stomach upset and diarrhea. The drug contains propylene glycol (E1520) - 20.70 mg in 1 ml. The drug contains methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) - may cause allergic reactions (possible late-type reactions). This medicine contains sodium - less than 1mmol (23mg) of sodium in 40ml, ie essentially 'sodium-free'.
Do not use in case of hypersensitivity to any component of the drug. Do not use in the case of a current gout attack (severe joint pain with swelling and redness of the skin or there is exudation in the large joints), when tests have shown an increased level of uric acid in the blood.
Side inosine pranobex, antiviral syrup effects:
Some people may experience side effects while taking the drug. Severe allergic reactions are very rare. If you experience symptoms such as sudden wheezing, difficulty breathing, swelling of the eyelids, face or lips, rash or itching (especially if they affect the entire body), stop taking the medicine immediately and consult your doctor immediately. Side effects: very common - increase in uric acid in the blood, increase in uric acid in the urine; common - increase in liver enzymes, increase in blood urea nitrogen, nausea with or without vomiting, epigastric discomfort, itching of the skin, skin rash (as the only symptom), headache, dizziness, fatigue or malaise, joint pain; uncommon - diarrhea, constipation, nervousness, sleepiness or difficulty sleeping (insomnia), increased urine volume (polyuria); Not known - angioedema (severe allergic reaction which causes swelling of the face, lips, tongue or throat which may cause difficulty in swallowing and breathing), allergic reaction, hives, anaphylactic reaction (sudden life-threatening allergic reaction affecting the whole body), dizziness scalp, reddening of the skin (erythema), upper abdominal discomfort.
Dosage of Inuprin Forte 100mg / ml inosine pranobex, antiviral syrup:
Use the drug as prescribed by your doctor or according to the instructions on the leaflet. Use orally. The dose is based on the patient's body weight. The daily dose should be divided into equal single doses administered several times a day. Adults, the elderly: the recommended daily dose is 50 mg / kg body weight per day (0.5 ml of syrup per 1 kg body weight per day), usually 3 g (i.e. 30 ml of syrup) per day, administered in 3 or 4 divided doses. The maximum daily dose: 4 g of inosine pranobex (40 ml of syrup). The maximum daily dose should not be exceeded. Children over 1 year of age: the usual recommended dose is 50 mg / kg body weight per day (0.5 ml of syrup per 1 kg body weight per day) in 3 or 4 equal divided doses throughout the day. Body weight: 10-14 kg - 3 x 2.5 ml of syrup, 15-20 kg - 3 x 2.5-3.75 ml of syrup, 21-30 kg - 3 x 3.75 - 5 ml of syrup, 31-40 kg - 3 x 5-7.5 ml of syrup, 41-50 kg - 3 x 7.5-8.75 ml of syrup. Do not exceed the recommended doses. Measure the syrup with the measuring cup attached to the package. Duration of treatment: usually 5 to 14 days. If there is no improvement or deterioration after this time, consult your doctor. It is recommended that after the symptoms of the disease have subsided, the drug should be continued for 1 to 2 days.